The In Silico Modeling and Simulation Conference to Enable Healthcare Innovation
29 - 30 March, 2022
| Online Event
Conference Day One: Medical Devices
9:00 am - 10:00 am
EST
The Executive Vision
Prith Banerjee -
Chief Technology Officer,
Ansys
Randy Schiestl - PMP, Vice President, Research & Development, Boston Scientific
Ram Rangarajan - Vice President, Stryker
For many years, leading companies such as Boston Scientific and Stryker have engaged with Ansys, building a vision for personalized and digitalized healthcare to accelerate medical innovation. Executive leaders from these three organizations will share their vision and explain why adopting and deploying engineering simulation is a critical path forward for their organization.
10:00 am - 11:00 am
EST
The Engineering Achievements
Ehsan Sarshari -
Associate Manager R&D, Simulations,
Stryker
Dana J. Coombs Phd. - Senior Principal Engineer, DePuy Synthes Trauma, J&J
Sonalee Tambat - Director, R&D Surgical Instrumentation, Alcon
Successful engineering leaders in the most innovative medical device companies such as Johnson & Johnson, Alcon, and Stryker routinely use Computer Modeling & Simulation (CM&S) to design safer, more efficient, and more affordable orthopedic implants and surgical equipment. Speakers will use multiple examples to show the concrete value and increasing importance of in silico methods for medical device companies.
11:00 am - 12:00 pm
EST
Panel: The Process to Adopt and Deploy
Thierry Marchal -
Program Director, Healthcare Solutions,
Ansys
Marc Horner - Senior Principal Application Engineer, Ansys
Alejandro Frangi - Diamond Jubilee Chair in Computational Medicine, University of Leeds
Dave Flynn - R&D Fellow on the Computational Modeling & Simulation, Boston Scientific
Mauricio Toro - Co-Founder & CEO, TECHFIT Digital Surgery
Pras Pathmanathan - Computational Scientist at FDA -- Lead, OSEL Credibility of Computational Models Regulatory Science Program
Tony Kaufman - New Business Development, 3M Medical Materials and Technologies
Despite the success of Computer Modeling & Simulation (CM&S) for medical device companies, some decision-makers remain intimidated or uncertain about the most efficient way to adopt and deploy CM&S. This prestigious panel of in silico methods veterans, including regulators (FDA), technical leaders from large companies (Boston Scientific & Ansys), a CEO of a startup (TECHFIT), and an academic thought leader (University of Leeds) will discuss the ideal ecosystem interactions for adopting engineering simulation effectively from a time and cost perspective.
Pras Pathmanathan
Computational Scientist at FDA -- LeadOSEL Credibility of Computational Models Regulatory Science Program
